Literature DB >> 17485383

Transforming growth factor-beta signaling in breast cancer.

Ching-Fang Chang1, Reyhan Westbrook, Jun Ma, Deliang Cao.   

Abstract

Transforming growth factor-beta (TGF-beta) is a multifunctional polypeptide that regulates cell growth, differentiation, and extracellular matrix formation. Studies on genetically engineered animal models have demonstrated that TGF-beta-mediated signaling pathway plays a critical role in both normal development and tumorigenesis of the breast. In pathogenesis of breast cancer, the role of TGF-beta appears featured with growth-inhibitory effects at early stages of carcinogenesis, but aggressive oncogenesis with transition to more advanced malignant states. The TGF-beta signaling pathway is also tissue-context and ligand content-dependent. Therein, therapeutic modulation of TGF-beta signaling may be a multifactorial event.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485383     DOI: 10.2741/2396

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  13 in total

1.  F2-isoprostanes and Metabolite, and Breast Cancer Risk.

Authors:  Qi Dai; Xiangzhu Zhu
Journal:  N Am J Med Sci (Boston)       Date:  2009-07

2.  Oxidative Stress and Breast Cancer Risk in Premenopausal Women.

Authors:  Hazel B Nichols; Chelsea Anderson; Alexandra J White; Ginger L Milne; Dale P Sandler
Journal:  Epidemiology       Date:  2017-09       Impact factor: 4.822

Review 3.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

4.  Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.

Authors:  Molly A Taylor; Jay D Amin; Dawn A Kirschmann; William P Schiemann
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

5.  Nodal and activin receptor-like kinase 7 induce apoptosis in human breast cancer cell lines: Role of caspase 3.

Authors:  Yu Zhong; Guoxiong Xu; Gang Ye; Daniel Lee; Joseph Modica-Amore; Chun Peng
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2009-02-27

6.  Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's Health Study.

Authors:  Qi Dai; Yu-Tang Gao; Xiao-Ou Shu; Gong Yang; Ginger Milne; Qiuyin Cai; Wanqing Wen; Nathaniel Rothman; Hui Cai; Honglan Li; Yongbing Xiang; Wong-Ho Chow; Wei Zheng
Journal:  J Clin Oncol       Date:  2009-04-20       Impact factor: 44.544

7.  Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.

Authors:  H Tian; J Liu; J Chen; M L Gatza; G C Blobe
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

8.  Dual effects of TGF-beta on ERalpha-mediated estrogenic transcriptional activity in breast cancer.

Authors:  Yongsheng Ren; Liyu Wu; Andra R Frost; William Grizzle; Xu Cao; Mei Wan
Journal:  Mol Cancer       Date:  2009-11-27       Impact factor: 27.401

9.  Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast.

Authors:  M Bauer; G Su; C Casper; R He; W Rehrauer; A Friedl
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

10.  TGF-beta1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival.

Authors:  L Mu; D Katsaros; L Lu; M Preti; A Durando; R Arisio; H Yu
Journal:  Br J Cancer       Date:  2008-09-30       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.